Simplify Asset Management Inc. Makes New $205,000 Investment in Delcath Systems, Inc. (NASDAQ:DCTH)

Simplify Asset Management Inc. purchased a new position in shares of Delcath Systems, Inc. (NASDAQ:DCTH) during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor purchased 17,000 shares of the company’s stock, valued at approximately $205,000. Simplify Asset Management Inc. owned 0.05% of Delcath Systems as of its most recent SEC filing.

Other hedge funds have also made changes to their positions in the company. Polar Asset Management Partners Inc. purchased a new stake in Delcath Systems in the 3rd quarter valued at about $1,594,000. Principal Financial Group Inc. acquired a new stake in shares of Delcath Systems in the third quarter worth approximately $808,000. Virtu Financial LLC acquired a new position in Delcath Systems during the third quarter worth approximately $289,000. Baader Bank Aktiengesellschaft purchased a new position in shares of Delcath Systems in the 4th quarter worth $204,000. Finally, Charles Schwab Investment Management Inc. purchased a new position in shares of Delcath Systems in the 4th quarter worth about $156,000. Institutional investors and hedge funds own 61.12% of the company’s stock.

Wall Street Analyst Weigh In

Several equities research analysts have issued reports on DCTH shares. HC Wainwright boosted their price objective on shares of Delcath Systems from $22.00 to $24.00 and gave the stock a “buy” rating in a research note on Friday, March 7th. Craig Hallum increased their price target on Delcath Systems from $18.00 to $21.00 and gave the company a “buy” rating in a report on Friday, January 17th. One research analyst has rated the stock with a hold rating and four have issued a buy rating to the company’s stock. According to MarketBeat.com, Delcath Systems currently has a consensus rating of “Moderate Buy” and an average price target of $22.75.

Delcath Systems Price Performance

Shares of DCTH stock opened at $13.72 on Friday. The company’s fifty day moving average price is $14.55 and its two-hundred day moving average price is $11.91. The firm has a market capitalization of $458.29 million, a P/E ratio of -10.16 and a beta of 0.82. Delcath Systems, Inc. has a 12 month low of $4.26 and a 12 month high of $16.97.

Delcath Systems (NASDAQ:DCTH) last released its quarterly earnings results on Thursday, March 6th. The company reported ($0.11) EPS for the quarter, missing the consensus estimate of ($0.10) by ($0.01). Delcath Systems had a negative return on equity of 338.16% and a negative net margin of 150.70%. The business had revenue of $15.10 million during the quarter, compared to analyst estimates of $14.96 million. During the same quarter last year, the firm posted ($0.48) EPS. On average, sell-side analysts anticipate that Delcath Systems, Inc. will post -0.79 EPS for the current year.

Delcath Systems Company Profile

Delcath Systems, Inc, an interventional oncology company, focuses on the treatment of primary and metastatic liver cancers in the United States and Europe. The company’s lead product candidate is HEPZATO KIT, a melphalan for injection/hepatic delivery system to administer high-dose chemotherapy to the liver while controlling systemic exposure and associated side effects.